TWO SIGMA ADVISERS, LP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$10,092,422
-27.4%
525,100
-4.0%
0.03%
-25.7%
Q2 2023$13,904,740
-28.2%
547,000
+2.1%
0.04%
-30.0%
Q1 2023$19,361,940
+34.6%
535,600
+47.5%
0.05%
+25.0%
Q4 2022$14,382,720
-16.5%
363,200
-1.8%
0.04%
-20.0%
Q3 2022$17,233,000
+23.3%
369,800
+16.0%
0.05%
+25.0%
Q2 2022$13,973,000
-19.5%
318,800
+32.9%
0.04%
-13.0%
Q1 2022$17,352,000
+57.6%
239,900
+76.7%
0.05%
+64.3%
Q4 2021$11,009,000
-19.2%
135,800
+39.0%
0.03%
-24.3%
Q1 2021$13,629,000
-42.1%
97,700
-28.1%
0.04%
-41.3%
Q4 2020$23,524,000
-1.1%
135,900
-20.4%
0.06%
-7.4%
Q3 2020$23,779,000
-14.2%
170,700
-26.5%
0.07%
-16.0%
Q2 2020$27,729,000
+8.5%
232,100
-9.2%
0.08%
-17.3%
Q1 2020$25,545,000
+42.1%
255,500
+67.1%
0.10%
+133.3%
Q4 2019$17,972,000
+2471.1%
152,900
+2182.1%
0.04%
+1300.0%
Q3 2016$699,000
+31.4%
6,700
-32.3%
0.00%
-25.0%
Q2 2015$532,0009,9010.00%
Other shareholders
NEVRO CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders